Tinea pedis, both in its acute and chronic phase, is a common skin condition that often is overlooked but can lead to
onychomycosis and acute bacterial
cellulitis if left untreated. Therefore, aggressive treatment with a topical
antifungal agent is warranted.
Sertaconazole nitrate cream 2% is a newer
imidazole agent that possesses both fungicidal and fungistatic properties to eradicate existing
infections. In addition to antifungal properties, it exhibits anti-inflammatory and
antipruritic effects. Controlled clinical trials have confirmed its safety, tolerability, and efficacy in participants with
tinea pedis. We report 2 patients with chronic
tinea pedis of many years' duration and demonstrate the usefulness of
sertaconazole nitrate cream 2% in the clinical setting.
Tinea pedis was confirmed by results of a
potassium hydroxide preparation. Both patients experienced marked improvement by the second week of twice-daily treatment with
sertaconazole nitrate cream 2%. Clinical cure was achieved in both patients. These findings suggest that
sertaconazole nitrate cream 2% is an effective option for the treatment of
tinea pedis.